Biodexa Pharmaceuticals PLC (BDRX)

5.70 +0.02 (+0.35%) USD  |  NASDAQ  |  Nov 05, 11:19
More

Biodexa Pharmaceuticals Revenue Estimates for Current Fiscal Year

Revenue Estimates for Current Fiscal Year Chart

View Revenue Estimates for Current Fiscal Year for BDRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Revenue Estimates for Current Fiscal Year Data

View and export this data back to 2023. Upgrade now.
Date Value
June 04, 2024 --
February 08, 2024 --
Date Value
December 31, 2023 --

Revenue Estimates for Current Fiscal Year Range, Past 5 Years

--
Minimum
Feb 08 2024
Upgrade
Maximum
Dec 31 2023
Upgrade
Average
Upgrade
Median
Jun 04 2024

Revenue Estimates for Current Fiscal Year Benchmarks

Adaptimmune Therapeutics PLC Upgrade
Verona Pharma PLC Upgrade
NuCana PLC Upgrade
Autolus Therapeutics PLC Upgrade
TC BioPharm (Holdings) PLC Upgrade

Revenue Estimates for Current Fiscal Year Related Metrics

Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade